Quick Takeaways
- Sio Capital Management, LLC filed SCHEDULE 13G/A for PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 per share (PMVP).
- Disclosed ownership: 5.8%.
- Date of event: 31 Mar 2026.
Sio Capital Management, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 per share (PMVP)
- Filing Manager
- Sio Capital Management, LLC
- Reporting Manager
- Sio Capital Management, LLC
- Symbol
- PMVP
- Shares outstanding
- 53,320,277 shares
- Disclosed Ownership
- 3,076,580 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 May 2026, 16:14:14 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 12 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sio Capital Management, LLC disclosed 5.8% ownership in PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 per share (PMVP) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 12 Nov 2025.
- Current filing was accepted on 04 May 2026, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC | 5.8% | 3,076,580 | 0 | 3,076,580 | /s/ Jin W. Lee | Chief Compliance Officer |